BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15316317)

  • 1. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations.
    Shih IM; Kurman RJ
    Am J Surg Pathol; 2004 Sep; 28(9):1177-83. PubMed ID: 15316317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental site nodule and characterization of distinctive types of intermediate trophoblast.
    Shih IM; Seidman JD; Kurman RJ
    Hum Pathol; 1999 Jun; 30(6):687-94. PubMed ID: 10374778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
    Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
    Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor.
    Stichelbout M; Devisme L; Franquet-Ansart H; Massardier J; Vinatier D; Renaud F; Kerdraon O
    Hum Pathol; 2016 Aug; 54():121-6. PubMed ID: 27068524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathology of intermediate trophoblastic tumors and tumor-like lesions.
    Shih IM; Kurman RJ
    Int J Gynecol Pathol; 2001 Jan; 20(1):31-47. PubMed ID: 11192071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis.
    Singer G; Kurman RJ; McMaster MT; Shih IeM
    Am J Surg Pathol; 2002 Jul; 26(7):914-20. PubMed ID: 12131159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma.
    Shih IM; Kurman RJ
    Am J Surg Pathol; 1998 Nov; 22(11):1393-403. PubMed ID: 9808132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic study of tumors of intermediate trophoblasts].
    Li BZ; Zhu L; Duan W
    Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):722-6. PubMed ID: 17374255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic Tumors.
    Jeremie G; Allias F; Trecourt A; Gaillot-Durand L; Bolze PA; Descotes F; Tondeur G; Perrot J; Hajri T; You B; Golfier F; Lopez J; Devouassoux-Shisheboran M
    Mod Pathol; 2023 Jan; 36(1):100046. PubMed ID: 36788063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression.
    Lee Y; Kim KR; McKeon F; Yang A; Boyd TK; Crum CP; Parast MM
    Hum Pathol; 2007 Jul; 38(7):1003-1013. PubMed ID: 17397906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
    Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM
    Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational trophoblastic neoplasia: Novelties and challenges.
    Silva ALMD; Monteiro KDN; Sun SY; Borbely AU
    Placenta; 2021 Dec; 116():38-42. PubMed ID: 33685753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
    Shih IM; Kurman RJ
    Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies.
    Shih IM; Kurman RJ
    Hum Pathol; 1998 Jan; 29(1):27-33. PubMed ID: 9445130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a cell: reflections on the checkered history of intermediate trophoblast and update on its nature and pathologic manifestations.
    Kurman RJ; Shih IeM
    Int J Gynecol Pathol; 2014 Jul; 33(4):339-47. PubMed ID: 24901393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of PD-L1 expression in trophoblastic tissues and tumors.
    Lu B; Teng X; Fu G; Bao L; Tang J; Shi H; Lu W; Lu Y
    Hum Pathol; 2019 Feb; 84():202-212. PubMed ID: 30339966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions.
    Xue WC; Khoo US; Ngan HY; Chan KY; Ip PP; Tsao SW; Cheung AN
    Int J Gynecol Pathol; 2004 Apr; 23(2):145-50. PubMed ID: 15084843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
    Shih IM; Kurman RJ
    Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental site trophoblastic tumor: human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers.
    Rhoton-Vlasak A; Wagner JM; Rutgers JL; Baergen RN; Young RH; Roche PC; Plummer TB; Gleich GJ
    Hum Pathol; 1998 Mar; 29(3):280-8. PubMed ID: 9496832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical Placental Site Nodule Arising in a Postcesarean Section Scar: Case Report and Review of the Literature.
    McCarthy WA; Paquette C; Colavita M; Lawrence WD
    Int J Gynecol Pathol; 2019 Jan; 38(1):71-75. PubMed ID: 29140877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.